Expanding Daily Oral PrEP To Persons At High Risk Of HIV May Accelerate Reductions In New HIV Diagnoses In The US, Researchers Say
April 10, 2020
Infectious Disease Advisor (4/9, Masoud) reports, “Expanding daily oral antiretroviral pre-exposure prophylaxis (PrEP) to persons at high risk for HIV may accelerate the reductions in new HIV diagnoses in the” US, researchers concluded after examining “da...